Page last updated: 2024-09-03

2'-deoxy-2'-methylenecytidine and 1-arabinofuranosylcytosine-5'-stearylphosphate

2'-deoxy-2'-methylenecytidine has been researched along with 1-arabinofuranosylcytosine-5'-stearylphosphate in 1 studies

Compound Research Comparison

Studies
(2'-deoxy-2'-methylenecytidine)
Trials
(2'-deoxy-2'-methylenecytidine)
Recent Studies (post-2010)
(2'-deoxy-2'-methylenecytidine)
Studies
(1-arabinofuranosylcytosine-5'-stearylphosphate)
Trials
(1-arabinofuranosylcytosine-5'-stearylphosphate)
Recent Studies (post-2010) (1-arabinofuranosylcytosine-5'-stearylphosphate)
302057172

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsukagoshi, S1

Reviews

1 review(s) available for 2'-deoxy-2'-methylenecytidine and 1-arabinofuranosylcytosine-5'-stearylphosphate

ArticleYear
[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:7

    Topics: Animals; Antimetabolites, Antineoplastic; Arabinonucleotides; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Cytidine Monophosphate; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation

1997